Prostate Imaging—PET: 18 F-Fluciclovine (Axumin)

Journal of Nuclear Medicine Technology 2026

View at publisher
Authors: Mary Beth Farrell, Kathy S. Thomas, Eleanor S. Mantel, Jessica Settle
DOI: 10.2967/jnmt.126.272483
Cited by: 1
References: 2

Abstract

18F-fluciclovine, commercially known as Axumin, is a synthetic amino acid that detects an increase or upregulation of amino acid transport, which occurs in prostate cancer. This amino acid analog is used in patients with suspected prostate cancer recurrence based on elevated blood prostate-specific

Fields of Study & Subjects

Amino Acid Enzymes and Metabolism Prostate Cancer Treatment and Research Cancer Hypoxia and Metabolism

Publication details

Journal / source
Journal of Nuclear Medicine Technology
Publisher
Society of Nuclear Medicine
Volume
54
Issue
2
Pages
164–165
Publication date
31 March 2026
Language
EN